IL-33trap is a novel IL-33 neutralizing biologic that inhibits allergic airway inflammation

BACKGROUND: The emergence of IL-33 as a key molecular player in the development and propagation of widespread inflammatory diseases including asthma and atopic dermatitis has established the need for effective IL-33 neutralizing biologics. OBJECTIVE: Here we describe the development and validation o...

Full description

Saved in:
Bibliographic Details
Published in:J Allergy Clin Immunol
Main Authors: Holgado, Aurora, Braun, Harald, Van Nuffel, Elien, Detry, Sammy, Schuijs, Martijn J., Deswarte, Kim, Vergote, Karl, Haegman, Mira, Baudelet, Griet, Haustraete, Jurgen, Hammad, Hamida, Lambrecht, Bart N., Savvides, Savvas N., Afonina, Inna S., Beyaert, Rudi
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7610802/
https://ncbi.nlm.nih.gov/pubmed/30876911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2019.02.028
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items